™Your Policy Risk Impact Agent
98 chapters · 1,453 sections in this title.
RCW 70.405.010 Definitions.
1.3K chars
The definitions in this section apply throughout this chapter unless the context clearly requires otherwise. (1) "Authority" means the health care authority. (2) "Biological product" has the same meaning as in 42 U.S.C. Sec. 262(i)(1). (3) "Biosimilar" has the same meaning as in …
RCW 70.405.020 Prescription drug affordability board.
3.6K chars
(1) The prescription drug affordability board is established, to include five members who have expertise in health care economics or clinical medicine appointed by the governor. (2) Board members shall serve for a term of five years and members may be reappointed by the governor …
RCW 70.405.030 Authority to review drug prices.
1.3K chars
By June 30, 2023, and annually thereafter, utilizing data collected pursuant to chapters 43.71C, 43.371, and 70.390 RCW, or other data deemed relevant by the board, the board must identify prescription drugs that have been on the market for at least seven years, are dispensed at …
RCW 70.405.040 Affordability reviews.
3.0K chars
(1) The board may choose to conduct an affordability review of up to 24 prescription drugs per year identified pursuant to RCW 70.405.030. When deciding whether to conduct a review, the board shall consider: (a) The class of the prescription drug and whether any therapeutically e…
